CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Samil Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Samil Pharmaceutical Co Ltd
Samil Pharmaceutical Office Bldg.
155, Hyoryeong-ro, Seocho-gu
Phone: +82 25200300p:+82 25200300 SEOUL, 06666  South Korea Ticker: 000520000520
Business Summary
SAMIL PHARMACEUTICAL CO., LTD is a Korea-based company mainly engaged in the manufacture of medicines. The Company’s products portfolio consists of gastro-intestinal drugs such as antiulcerants, gastroprokinetic agents, digestive enzymes with nutrients and laxatives under the brand names of Plybutine, Gliptide and others; antipyretic, analgesic and anti-inflammatory agents under the brand name Brufen; nutritional supplements such as vitamins, minerals and immunosuppressants, and others including antigout agents, anti-parkinsonism agents and others. In addition, it is engaged in the provision of miscellaneous goods. The Company distributes its products within domestic market and to overseas markets. On November 29, 2013, it transferred its entire shares of a Korea-based company, which is engaged in the sale of medical products.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations
6512 Operators of nonresidential buildings

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President V.S. S.Ram 62
Chief Executive Officer, Director Seung BeomHuh 43 9/30/2024 3/22/2013
Vice President, Director Bu HwanGoh 57 1/1/2011 3/21/2008
7 additional Officers and Directors records available in full report.

Business Names
Business Name
000520
Samil Pharmaceutical Co., Ltd
Samil Pharmaceutical Co., Ltd.

General Information
Number of Employees: 395 (As of 12/31/2014)
Outstanding Shares: 21,229,653 (As of 11/22/2024)
Shareholders: 9,937
Stock Exchange: KRX
Fax Number: +82 25880988


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024